Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Treace Medical Concepts (TMCI) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to 31.22%.

  • Treace Medical Concepts' EBIT Margin rose 23500.0% to 31.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 22.13%, marking a year-over-year increase of 85600.0%. This contributed to the annual value of 26.6% for FY2024, which is 8800.0% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' EBIT Margin is 31.22%, which was up 23500.0% from 35.82% recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' EBIT Margin ranged from a high of 0.3% in Q4 2024 and a low of 48.1% during Q2 2024
  • In the last 5 years, Treace Medical Concepts' EBIT Margin had a median value of 31.11% in 2023 and averaged 26.96%.
  • Per our database at Business Quant, Treace Medical Concepts' EBIT Margin plummeted by -318200bps in 2021 and then skyrocketed by 122800bps in 2025.
  • Over the past 5 years, Treace Medical Concepts' EBIT Margin (Quarter) stood at 16.74% in 2021, then soared by 58bps to 7.03% in 2022, then tumbled by -55bps to 10.9% in 2023, then soared by 97bps to 0.3% in 2024, then plummeted by -10414bps to 31.22% in 2025.
  • Its EBIT Margin stands at 31.22% for Q3 2025, versus 35.82% for Q2 2025 and 29.64% for Q1 2025.